BRCA2 and ovarian carcinoma: At this time, the NCCN [52] and ACOG [54] guidelines suggest that for patients with BRCA1 or BRCA2 mutations, pelvic ultrasound and CA125 every 6 months may be considered for the detection of early ovarian cancer.